Literature DB >> 1555333

Free vascularized fibula grafting for the treatment of osteonecrosis of the femoral head.

M C Yoo1, D W Chung, C S Hahn.   

Abstract

A variety of joint-preserving operations have been devised to preserve the necrotic femoral head with varying success. Since 1979, the authors studied the effectiveness of vascularized fibula grafting in the treatment of osteonecrosis of the femoral head (ONFH) for joint preservation. Eighty-one of 121 hips with a minimum follow-up period ranged from three years to ten years eight months (mean, five years two months). All patients were evaluated clinically and roentgenographically on the basis of the causes and the stages of the disease. In the clinical assessment, 60 (74%) of 81 hips were rated excellent, 14 (17%) were rated good, six (7%) were rated fair, and one (2%) was rated poor. Overall satisfactory results, including excellent and good, were seen in 74 hips (91%). In the roentgenographic assessment, 57 hips (71%) had improved radiologically, 15 (18%) were unchanged, and nine (11%) were worse. Seventy-two hips (89%) showed roentgenographic improvement or unchange. Roentgenographic results had no significant correlation with the etiologic factors. Vascularized fibula grafting is one of the better alternatives for treating ONFH. It is highly expected that vascularized fibula grafting can prevent the necrotic femoral head from progressing to collapse and promote directly restored vascularization and new bone formation.

Entities:  

Mesh:

Year:  1992        PMID: 1555333

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  15 in total

1.  Open reduction and cementation for femoral head fracture secondary to avascular necrosis: preliminary report.

Authors:  M L Wood; C M McDowell; T L Kerstetter; S S Kelley
Journal:  Iowa Orthop J       Date:  2000

2.  The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.

Authors:  Qiang Mao; Hongting Jin; Fei Liao; Luwei Xiao; Di Chen; Peijian Tong
Journal:  Bone       Date:  2013-08-29       Impact factor: 4.398

3.  The role of platelet rich plasma in management of fracture neck femur: new insights.

Authors:  Ahmed Mohamed Samy
Journal:  Int Orthop       Date:  2015-07-09       Impact factor: 3.075

4.  Will a vascularized greater trochanter graft preserve the necrotic femoral head?

Authors:  Dewei Zhao; Benjie Wang; Lin Guo; Lei Yang; Fengde Tian
Journal:  Clin Orthop Relat Res       Date:  2009-11-07       Impact factor: 4.176

5.  Treatment of osteonecrosis of the femoral head with vascularized bone grafting.

Authors:  Patrick D Millikan; Vasili Karas; Samuel S Wellman
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

6.  Endoprostheses for osteonecrosis of the femoral head. A comparison of four models in young patients.

Authors:  M J Grecula; P Grigoris; T P Schmalzried; F Dorey; P A Campbell; H C Amstutz
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

7.  Long-term followup of vascularized fibular grafting for femoral head necrosis.

Authors:  Myung-Chul Yoo; Kang-Il Kim; Chung-Soo Hahn; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2008-03-11       Impact factor: 4.176

Review 8.  Do modern techniques improve core decompression outcomes for hip osteonecrosis?

Authors:  David R Marker; Thorsten M Seyler; Slif D Ulrich; Siddharth Srivastava; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-04-08       Impact factor: 4.176

9.  Failed vascularized fibular graft in treatment of osteonecrosis of the femoral head. A histopathological analysis.

Authors:  Maria Chiara Meloni; W Russalka Hoedemaeker; Victor Fornasier
Journal:  Joints       Date:  2016-06-13

Review 10.  Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment.

Authors:  Jeremy T Hines; Woo Lam Jo; Quanjun Cui; Michael A Mont; Kyung Hoi Koo; Edward Y Cheng; Stuart B Goodman; Yong Chan Ha; Phillippe Hernigou; Lynne C Jones; Shin Yoon Kim; Takashi Sakai; Nobuhiko Sugano; Takuaki Yamamoto; Mel S Lee; Dewei Zhao; Wolf Drescher; Tae Young Kim; Young Kyun Lee; Byung Ho Yoon; Seung Hoon Baek; Wataru Ando; Hong Seok Kim; Jung Wee Park
Journal:  J Korean Med Sci       Date:  2021-06-21       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.